Piper Sandler raises target for Viatris stock to USD 14.00 from USD 13.00

Published on 10/27/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Viatris stock trades at EUR 16.47 on October 27, 2026, 0.91 percent above the Xetra close. Results arrive November 5, 2026.

Acquisition and analyst signals

Viatris agreed to acquire Pacira for USD 1.65 billion on October 8, 2026.
Piper Sandler raised its Viatris target from USD 13.00 to USD 14.00 on October 26, 2026.
Viatris stock trades at EUR 16.47 at 1:30 p.m. CEST at Lang & Schwarz on October 27, 2026, 0.91 percent above the Xetra close of October 26, 2026.
Viatris will report third-quarter 2026 results on November 5, 2026.

Viatris, US92556V1061, Illustration mit AI erstellt.

Viatris (ISIN US92556V1061) stock is tied to a fresh analyst move: MarketScreener reported on October 26, 2026 that Piper Sandler raised its price target from USD 13.00 to USD 14.00 while keeping a Neutral rating. Viatris was trading at EUR 16.47 at Lang & Schwarz on October 27, 2026 at 1:30 p.m. CEST, up 0.91 percent versus the Xetra close of October 26, 2026 at EUR 16.32.

Targets diverge from the market price

The Piper Sandler target remains below Viatris' Nasdaq price context, highlighting a cautious view despite the higher target. MarketScreener listed Viatris at USD 18.29 at the Nasdaq close on October 26, 2026, with a market capitalization of USD 21.0 billion and a 52-week range of USD 9.92 to USD 18.75.

The latest target change followed another broker action. MarketScreener listed JPMorgan's October 21, 2026 target change from USD 18.00 to USD 20.00. The spread between the two targets makes the November results a key test of the market's expectations.

What does the Pacira deal add?

Viatris agreed on October 8, 2026 to acquire Pacira BioSciences for USD 36.50 per share in cash, valuing the transaction at USD 1.65 billion, according to the Viatris release. Pacira generated USD 746.0 million in revenue and USD 177.0 million in adjusted EBITDA during the twelve months ended June 30, 2026.

Three recent milestones

On October 8, 2026, Viatris announced the USD 1.65 billion Pacira acquisition. On October 21, 2026, JPMorgan raised its target from USD 18.00 to USD 20.00. On October 26, 2026, Piper Sandler lifted its target from USD 13.00 to USD 14.00.

Dates for the next decision

Viatris will report third-quarter 2026 financial results on November 5, 2026, at 8:30 a.m. ET, according to the Viatris investor release. The Pacira transaction is expected to close by the end of 2026.

Stock holds above the Xetra close

The euro quote places Viatris 0.91 percent above the EUR 16.32 Xetra close, while the analyst targets point in different directions. The further course of trading is shown by the continuously updated real-time quote of Viatris stock.